Back to Search Start Over

Differences in SARS-COV-2 seroprevalence in the population of Cusco, Peru.

Authors :
Charles H
Fátima CV
Lucio V
María KA
Johar C
Kevin P
Luz BV
Guido GA
Eduarda BC
Sebastian MN
Heber QJ
Matilde QY
Karla ZV
Liesbeth HF
Javier RE
Juan SR
Antonio BO
Source :
Global epidemiology [Glob Epidemiol] 2023 Dec 17; Vol. 7, pp. 100131. Date of Electronic Publication: 2023 Dec 17 (Print Publication: 2024).
Publication Year :
2023

Abstract

Background: The spread of the coronavirus disease 2019 (COVID-19) in Peru has been reported at the regional level, few studies have evaluated its spread at the provincial level, in which the mechanisms could be different.<br />Methods: We conducted an analytical, cross-sectional, multistage observational population study to assess the seroprevalence of SARS-COV-2 at the provincial and urban/rural levels in a high-altitude setting. The sampling unit was the household, including a randomly selected family member. Sampling was performed using a data collection sheet on clinical and epidemiological variables. Chemiluminescence tests were used to detect total anti-SARS-COV-2 antibodies (IgG and IgM simultaneously). The percentages were adjusted to the sampling design.<br />Results: The overall prevalence in the region of Cusco was 25.9%, with considerably different prevalence between the 13 provinces (from 15.9% in Acomayo to 40.1% in Canchis) and between rural (21.1%) and urban (31.7%) areas. In multivariable model, living in a rural area was a protective factor (adjusted prevalence ratio [aPR], 0.68; 95% confidence interval [CI], 0.61-0.76).<br />Conclusions: Geographic diversity and population density determine different prevalence rates, typically lower in rural areas, possibly due to natural social distancing or limited interaction with people at risk.<br />Competing Interests: The authors declare no conflicts of interest. The funders nor authorities of the Gerencia Regional de Salud del Cusco had no role in the design of this study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.<br /> (© 2023 Published by Elsevier Inc.)

Details

Language :
English
ISSN :
2590-1133
Volume :
7
Database :
MEDLINE
Journal :
Global epidemiology
Publication Type :
Academic Journal
Accession number :
38188037
Full Text :
https://doi.org/10.1016/j.gloepi.2023.100131